Skip to main content

Pediatric Blood Cancer Initiatives & Advances Regarding Bone Marrow/Stem Cell Transplant and CAR T-cell Therapy

September 16, 2020

This one-hour program addressed the many unique needs and breakthrough advances designated to save and heal youngsters. Dr. Kevin J. Curran, Pediatric Director, Cellular Therapeutic Center of Memorial Sloan Kettering Cancer Center shared innovative treatment and progress, including information regarding CAR T-cell Therapy. Gwen Nichols, M.D., Chief Medical Officer of Blood Cancer United further discussed relevant initiatives and emerging therapies. Michelle Marks, mom to a pediatric transplant patient will share her best tips, experiences and coping skills. Jennifer Gillette, licensed staff social worker, facilitated this program. A Q&A session follows the program. Presented by The National Bone Marrow Transplant Link

Audio replay

Pediatric Blood Cancer Initiatives & Advances Regarding Bone Marrow/Stem Cell Transplant and CAR T-cell Therapy


Sponsors

Blood Cancer United, Jazz Pharmaceuticals, Incyte Corporation, Pharmacyclics & Janssen. We also would like to thank our esteemed link partners.

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.